Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.
Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S.
Crit Rev Microbiol. 2016 Nov;42(6):905-27. doi: 10.3109/1040841X.2015.1091805. Epub 2015 Dec 21.
Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy.
Sun Z, Ge X, Qiu B, Xiang Z, Jiang C, Wu J, Li Y.
Front Cell Infect Microbiol. 2023 Feb 3;13:1123026. doi: 10.3389/fcimb.2023.1123026. eCollection 2023.
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Sobel JD, Sobel R.
Expert Opin Pharmacother. 2018 Jun;19(9):971-977. doi: 10.1080/14656566.2018.1476490. Epub 2018 Jun 22.
Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion.
Donders G, Sziller IO, Paavonen J, Hay P, de Seta F, Bohbot JM, Kotarski J, Vives JA, Szabo B, Cepuliené R, Mendling W.
Front Cell Infect Microbiol. 2022 Sep 9;12:934353. doi: 10.3389/fcimb.2022.934353. eCollection 2022.
Biofilms and vulvovaginal candidiasis.
Rodríguez-Cerdeira C, Gregorio MC, Molares-Vila A, López-Barcenas A, Fabbrocini G, Bardhi B, Sinani A, Sánchez-Blanco E, Arenas-Guzmán R, Hernandez-Castro R.
Colloids Surf B Biointerfaces. 2019 Feb 1;174:110-125. doi: 10.1016/j.colsurfb.2018.11.011. Epub 2018 Nov 7.
Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial.
Wang X, Chen L, Ruan H, Xiong Z, Wang W, Qiu J, Song W, Zhang C, Xue F, Qin T, Zhang B, An R, Luo X, Wang W, Zhang S, Cai Y, Kang J, Deng H, Fan S, Cui M, Wang S, Luo X, Su Z, Shu J, Wang Q, Wang F, Bai J, Liao Q.
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0077823. doi: 10.1128/aac.00778-23. Epub 2023 Dec 14.
Recurrent vulvovaginal candidiasis.
Lines A, Vardi-Flynn I, Searle C.
BMJ. 2020 Jun 8;369:m1995. doi: 10.1136/bmj.m1995.
Advanced Solid Formulations For Vulvovaginal Candidiasis.
Conte J, Parize AL, Caon T.
Pharm Res. 2023 Feb;40(2):593-610. doi: 10.1007/s11095-022-03441-5. Epub 2022 Nov 30.
Recurrent vulvovaginal candidiasis.
Ringdahl EN.
Mo Med. 2006 Mar-Apr;103(2):165-8.
Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution.
David H, Solomon AP.
Front Cell Infect Microbiol. 2023 Oct 13;13:1245808. doi: 10.3389/fcimb.2023.1245808. eCollection 2023.
